344x Filetype PPTX File size 0.60 MB Source: www.esma.europa.eu
ESMA REGULAR USE
Contents
• Main findings
• UCITS analysis
– EU aggregate analysis
– Analysis by management type
– Funds by domicile
• UCITS ESG analysis
– Equity UCITS analysis
– Analysis by ESG rating
• SRPs analysis from PRIIPs
– Performance scenario analysis
– Costs analysis
• Retail AIFs
2
ESMA REGULAR USE
Main findings
Retail clients continue to pay high costs for investment
• UCITS funds
– Costs only marginally declined over time
– Retail clients paid around 40% more than institutional investors
– Active net underperformance compared to passive
– Outperformance of ESG funds mostly driven by sectoral factors
• Structural Retail Products
– Total costs attributable to entry costs and varied substantially by
country and payoff type
– Limited transparency and comparability across Member States.
Heterogeneity and data availability issues persisted
• Retail AIFs
– Returns in 2019 higher than 2018 reflecting strong valuation of
underlying assets
3
ESMA REGULAR USE
Investment funds - UCITS, EU aggregate analysis
Significant cost impact
• Costs
– Limited variability in costs
– Cost impact is higher the lower is
the performance: highest cost
impact in 2016 and 2018 leading
to negative net performance
• Performance
– Strong variations in annual
performance reflecting market
developments
4
ESMA REGULAR USE
Investment funds - UCITS, analysis by management type
Net underperformance of active funds
• Equity funds:
– Gross outperformance of passive and
ETFs fades away at long horizons
– However, costs significantly higher for
active compared to passive and
ETFs…
– …so, underperformance of active
UCITS, on average
• Top performing funds:
– Outperformance of the top-25% active
compared to the top-25% passive at
shorter horizons
– The cohort changes over time making
it complicated for investors to
consistently identify outperforming
UCITS
5
ESMA REGULAR USE
Investment funds - UCITS, funds by domicile
Fund- and investor-domicile analysis
• Strong decline in heterogeneity moving from fund- to investor-domicile
perspective
6
no reviews yet
Please Login to review.